Table 2.
Plasmid* | tra box† | β-Galactosidase activity‡
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Activation§
|
Repression¶
|
||||||||
TraR−
|
TraR+
|
TraR−
|
TraR+
|
||||||
AAI− | AAI+ | AAI− | AAI+ | AAI− | AAI+ | AAI− | AAI+ | ||
pZLb251/pPBL1 | ATGTGCAGATCTGCACGT | 1 | 1 | 11 | 392 | 89 | 97 | 86 | 5 |
pZLbm4-15/pLMB4-15 | ATGCGCAGATCTGCGCGT | 3 | 1 | 2 | 2 | 104 | 98 | 96 | 101 |
pZLb251-D/pPBL1-D | ATGTGCATGCACGT | 1 | 1 | 1 | 1 | 232 | 198 | 221 | 187 |
Each plasmid pair represents the constructs used for the activation and repression assays, respectively.
Underlined nucleotides in the tra box sequence identify the BglII site in its wild-type and deleted forms or the symmetrical base substitutions at the 4 and 15 positions.
Expressed as units per 108 colony-forming units. All values are the averages of three independent experiments with variations <10%.
Assessed in A. tumefaciens.
Assessed in E. coli DH5α.